SCHEMBL9533462

SCHEMBL9533462

c1ccc2sc([C]3CC3)nc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 12/20 0.56
NPC1 O15118 11/20 0.56
KDM4E B2RXH2 9/20 0.56
ALDH1A1 P00352 5/20 0.56
SMN1; SMN2 Q16637 5/20 0.56
TP53 P04637 2/20 0.56
HSD17B10 Q99714 2/20 0.56
TSHR P16473 1/20 0.56
MAPT P10636 6/20 0.55
L3MBTL1 Q9Y468 4/20 0.55
KMT2A Q03164 4/20 0.55
GAA P10253 3/20 0.55
MEN1 O00255 3/20 0.55
GLA P06280 2/20 0.55
APP P05067 2/20 0.55
TDP1 Q9NUW8 1/20 0.55
LMNA P02545 1/20 0.55
MMP9 P14780 1/20 0.55
MMP8 P22894 1/20 0.55
NPSR1 Q6W5P4 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5637618 0.92 RAB9A (0.53) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL19279180 0.90 RAB9A (0.51) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL827403 0.84 RAB9A (0.67) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
Hydrogen Sulfide SCHEMBL16859912 0.82 RAB9A (0.64) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL366824 0.78 RAB9A (0.81) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL9228500 0.78 APP (0.63) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL231307 0.78 KDM4E (0.75) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL29474819 0.78 RAB9A (0.81) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL24295138 0.77 RAB9A (0.79) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL3073946 0.77 RAB9A (0.69) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101001842-A Amido compounds and their use as pharmaceuticals INCYTE CORP (US) 2007-07-18 CN disclosed
EP-0313458-B1 IMIDAZO(2,1-B)BENZOTHIAZOLES AND THEIR ACID ADDITION SALTS, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1993-08-11 EP disclosed